Healthcare
Live Price
Offline$0.0001
+0.00% today
1Y Change
+0.00%
Window
Jun 23, 2025 → Jun 17, 2026
Coverage: 248 bars · Jun 23, 2025 → Jun 17, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
TransCanna Holdings Inc. (TCNAF) is a Healthcare stock with listed on OTC. The stock last traded around $0.00 and up 0.0% across the available one-year price window (Jun 23, 2025 → Jun 17, 2026). Baseline metrics include revenue growth of -42.5%, EPS growth of +41.0%, a dividend yield of 0.0%. What stands out right now is revenue -42.5%, EPS +41.0%, free cash flow -22.8% with operating margin -258.1% and ROIC -46.9%. Valuation is more restrained than many high-expectation growth names at price/sales 0.3. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines TCNAF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
TCNAF
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
TCNAF Max Drawdown
0.00%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for TCNAF and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$0.0
FY Net Income
-$191.4K
+91.1% YoY
Free Cash Flow
-$129.4K
+88.7% YoY
Revenue Growth
-42.5%
EPS Growth
+41.0%
Gross Margin
-21.3%
Net Margin
-377.4%
Income statement
CAD
| Metric | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|
| Revenue | 4M | 7M | 240K | 0 | 0 |
| Gross Profit | -850K | 194K | 140K | -6K | 0 |
| Operating Income | -9M | -10M | -13M | -2M | -191K |
| EBITDA | -10M | -10M | -26M | -2M | -191K |
| Net Income | -13M | -17M | -26M | -2M | -191K |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
CAD
| Metric | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|
| Cash & Equivalents | 241K | 1M | 3M | 74K | 81K |
| Total Assets | 26M | 26M | 33M | 412K | 169K |
| Total Liabilities | 22M | 17M | 16M | 665K | 15K |
| Shareholder Equity | 3M | 9M | 17M | -252K | 154K |
| Total Debt | 19M | 14M | 14M | 389K | 0 |
| Net Debt | 19M | 12M | 11M | 314K | -81K |
Cash flow positioning
Latest Full Year
Operating Cash Flow
66K
+94.1% YoY
Capital Expenditures
64K
-52.1% YoY
Free Cash Flow
129K
+88.7% YoY
Key ratios
Gross Margin
-21.3%
Operating Margin
-258.1%
Net Margin
-377.4%
ROE
-239.6%
Debt / Equity
5.75x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.